IARC reports marked differences in survival among patients diagnosed with cancer in countries in transition worldwide

A new study, published today in The Lancet Oncology, reports large international differences in survival among patients diagnosed with 15 common cancer types in Asia, Africa, and Latin America and the Caribbean. The project – Cancer Survival in Countries in Transition, Volume 3 (SURVCAN-3) – is a collaboration between the International Agency for Research on Cancer (IARC), the Global Initiative for Cancer Registry Development (GICR), and population-based cancer registries worldwide. As well as increasing the local capacity of registries to collect and produce high-quality data on cancer survival, SURVCAN-3 aims to benchmark national and subnational estimates of cancer survival across countries to aid in the assessment of national cancer control policies.

Soerjomataram I, Cabasag C, Bardot A, Fidler-Benaoudia MM, Miranda-Filho A, Ferlay J, et al.; on behalf of the SURVCAN-3 collaborators
Cancer survival in Africa, Central and South America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries
Lancet Oncol, Published online 3 January 2023;
https://doi.org/10.1016/S1470-2045(22)00704-5

Read IARC Press Release 327

Read the article

View the SURVCAN-3 online tool